McNeil Ads Defend Tylenol As Competitors "Demonize" Acetaminophen
This article was originally published in The Pink Sheet Daily
Executive Summary
McNeil and parent J&J launched a marketing campaign to defend Tylenol's safety just three days after a joint advisory committee recommended FDA lower the adult single and daily dose of acetaminophen to reduce hepatotoxicity risk.